Originally, ZFAS1 was first identified by Askarian-Amiri et al. (in 2011) [11], at that time, it was suggested to be lowly expressed in breast cancer, and had an antitumor effect on cell proliferation and differentiation. Here, ZFAS1 is linked to breast cancer.